A potent mix of bureaucratic red tape and adverse court rulings is deterring U.S. startups and small businesses from ...

Marn’i Washington, who directed her team to “avoid” homes “advertising Trump” in the response to Hurricane Milton, faces two ...

The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

Philanthropists Alfred and Gail Engelberg sold their lakefront Palm Beach home for $23.8 million, a steep discount from its ...

"We are dedicated to supporting parties involved in ANDA litigation," said WIT's Hatch-Waxman Chair Michael Crowe. "Our team has worked with hundreds of testifying experts in cases before district ...